Botulax 300U
Clostridium botulinum toxin type A
Invest in an even bigger dose of botulinum toxin solution with Botulax 300 units! It is formulated as a maximum-dose toxin solution, ideal for clinics with high product usage and for advanced medical and aesthetic procedures.
Botulax 300 units is available in 1 vial per box, containing 300 units of Clostridium botulinum Type A toxin.
- Packaging 1 × 300U vial
- Injection depth Intramuscular
- Duration 3–4 months
- Storage 2–8 °C
Description
Botulax 300 Units is the highest-volume product in the Botulax line by Hugel Inc., South Korea, intended for full-face rejuvenation, medical Botox procedures, and clinics that require high dosing efficiency. It contains botulinum toxin type A with the same purity, molecular stability, and predictable diffusion as the smaller unit options, but provides a more economical solution for extensive applications.
In 2009, Hugel introduced its first product, Botulax, which contains the Clostridium botulinum type A toxin. It has led the aesthetic injectable market in South Korea and established a standard for rivals. Years of research and development, along with clinical testing, have demonstrated its consistently high potency and remarkable purity. Mild to severe glabellar wrinkles and frown lines may be momentarily reduced by it. It also helps with blepharospasm, a disorder characterized by involuntary eyelid fluttering or twitching.
The price is really reasonable given its quality. Additionally, because medical professionals were involved in the development of Botulax, the solution provides users with customized dosages tailored to each unique need. This formulation is preferred in clinics that perform intricate neuromodulation procedures such as total-face relaxation treatments, calf slimming, and trapezius reshaping. For professional use in all therapeutic and aesthetic categories, the toxin is dependable due to its steady performance, even at high dosages.
Features of Botulax 300U
- Designed as a cost-optimized product, especially for high-volume users.
- Provides quick effects where results are visible as early as 3 days post-treatment.
- Maintains a stable potency, leading to a 24-hour storage capacity even after reconstitution.
- It is ideal for advanced medical procedures, such as facial defining and body slimming treatments
- Also ideal for masseter (jawline) treatment and wide-area rejuvenation
- Reduces the appearance of moderate to severe glabellar lines
- Produces natural outcomes after treatment
- Maintains a significantly prolonged duration of effect for a Botox solution, as once injected, it does not diffuse to other tissues surrounding the target area.
- Formulated with a highly purified (99%) Clostridium botulinum toxin Type A strain.
- Serves as a cost-efficient option, especially for high usage, such as in clinics
Application sites
Botulax 300 units are best administered for the following conditions:
- Lateral canthal lines (crow’s feet)
- Masseter or jawline definition
- Overall facial rejuvenation
- Advanced medical treatments, such as Body Botox, including calves, traps, and shoulders
- Therapeutic muscle spasm management
- Hyperhidrosis
Duration of effect
Typically, partial effects are initially observed within 3 days after the treatment session, and complete results are evident within 7–14 days post-treatment. Every Botulax 300U treatment lasts 3–4 months, depending on the treatment area (for example, in larger muscles, Botulax 300 units may last longer). It is also important to note that any Botox treatment that exceeds the 3-month treatment period may lead to product tolerance.
- Initial effect
- Within 3 days
- Full results
- 7–14 days
- Duration of effect
- 3–4 months
Product formulation
Botulax 300 units is formulated as a lyophilized powder for reconstitution before administration and contains the following components:
- Clostridium botulinum Toxin Type A – 300U
- Human serum albumin – 0.5 mg, and serves as a stabilizer
- Sodium chloride – 0.9 mg, acts as a tonic adjuster
Specifications
| Packaging | 1 × 300U vial |
| Product appearance | Lyophilized white powder for injection in a colorless transparent vial. It becomes a colorless, transparent liquid when mixed with a diluent (normal saline). |
| Composition | 300U Clostridium botulinum Toxin Type A, 0.5 mg Stabilizer (Human serum albumin), 0.9 mg Tonic adjuster (Sodium chloride) |
| Injection depth | Intramuscular |
| Cannula size | 27G–30G |
| Reconstitution | Mix the product with USP-grade saline solution only. |
| Treatment areas | Eyelids, glabella/frown lines, calf muscles, forehead, and hands |
| Treatment interval | Maintenance treatment sessions should be performed only 3 months after the initial procedure. This is to prevent tolerance to the product and overdosage. |
| Duration of effect | 3–4 months |
| Storage | Store at 2–8 °C or refrigerated in its hermetic container. |
| Shelf life | 36 months from manufacturing date |
| Manufacturer | Hugel Inc. |
Other Botulax strengths
Compare all five presentations side by side
Botulax 50U
A lower-unit presentation intended for professional use where the applicable product labeling calls for this strength, such as finer facial wrinkles and other superficial conditions.
Botulax 100U
A commonly supplied presentation containing 100 units of botulinum toxin type A per vial.
Botulax 150U
A convenient large-dose Botulax formulation for muscle spasticity and facial wrinkle improvement.
Botulax 200U
A higher-unit presentation intended for professional medical applications, as directed by the applicable labeling, especially in severe cases.
Questions about Botulax 300U?
For questions about product availability, specifications, documentation, or professional purchasing, please contact our team.